FindTrial
Sign In

The diagnostic value and the mechanism of ANP32E in the metastasic breast cancer

The diagnostic value and the mechanism of ANP32E in the metastasic breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ODT-12001957
Enrollment
Unknown
Registered
2012-02-02
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:
Index test:

Sponsors

Nanjing Maternity and Child Health Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: all cases of metastasic breast cancer

Exclusion criteria

Exclusion criteria: new cases of breast cancer and local recurrence of breast cancer

Design outcomes

Primary

MeasureTime frame
Anp32e expression;—

Countries

China

Contacts

Public ContactHong Yin
yy787832@163.com+86 025 52226265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026